Stay updated on Clinical Trial: AZD6094 + Docetaxel in MET+ Gastric Cancer
Sign up to get notified when there's something new on the Clinical Trial: AZD6094 + Docetaxel in MET+ Gastric Cancer page.

Latest updates to the Clinical Trial: AZD6094 + Docetaxel in MET+ Gastric Cancer page
- ChecktodayChange DetectedThe page now shows Revision: v3.5.4, replacing the previous v3.5.3, indicating a new revision of the page content.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThis updates the displayed software/page release revision from **v3.5.2** to **v3.5.3** without changing any of the clinical trial study content.SummaryDifference0.1%

- Check29 days agoChange DetectedAdded Revision: v3.5.2; Deleted Revision: v3.5.0.SummaryDifference0.1%

- Check44 days agoChange DetectedNo substantive changes are visible; the study details and eligibility criteria appear unchanged. Actionable items and sections remain the same across screenshots.SummaryDifference0.1%

- Check58 days agoChange DetectedRevision: v3.5.0 has been applied, replacing the previous v3.4.3.SummaryDifference0.1%

- Check72 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Clinical Trial: AZD6094 + Docetaxel in MET+ Gastric Cancer
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: AZD6094 + Docetaxel in MET+ Gastric Cancer page.